FDA illuminates new approval pathway for bespoke gene therapies - Fierce Biotech
FDA illuminates new approval pathway for bespoke gene therapies Fierce Biotech
FDA illuminates new approval pathway for bespoke gene therapies Fierce Biotech
Gene editing treatments could get easier FDA approval under new plan PennLive.com
Souped-Up CRISPR Gene Editor Replicates and Spreads Like a Virus SingularityHub
Gene editing that spreads within the body could cure more diseases New Scientist
A new CRISPR startup is betting regulators will ease up on gene-editing MIT Technology Review
Jennifer Doudna’s $1 Billion Plan To Bring Gene Editing To The Masses Forbes
Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments WIRED
We can rewrite our genetic code: Best ideas of the century New Scientist
The Chemistry of Genome Editing: Transforming Human and Planet Health with CRISPR C&EN
A Single Gene, a Dramatic Change: CRISPR Unlocks White Strawberries | Newswise Newswise
A Gene Editor That’s a Better Fit for Plants UC Davis
Assessing CRISPR Therapeutics (CRSP) Valuation As FDA Draft Guidance Speeds Rare Disease Genome Editing Approvals simplywall.st
Computation and deep-learning-driven advances in CRISPR genome editing Nature
Spatial CRISPR maps gene effects in the brain CRISPR Medicine
First-in-human trial of CRISPR gene-editing therapy safely lowered cholesterol, triglycerides www.heart.org
Best CRISPR Companies to Buy in 2026 and How to Invest in Them The Motley Fool
AI-powered CRISPR could lead to faster gene therapies, Stanford Medicine study finds Stanford Medicine
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3 | New England Journal of Medicine The New England Journal of Medicine
Therapeutic applications of CRISPR-Cas9 gene editing Frontiers
FDA’s Bespoke Pathway To Focus on Gene Editing and RNA-Based Treatments for Rare Diseases BioSpace
A Pint-Sized Gene Editor Could Expand Precision Breeding in Plants UC Davis College of Biological Sciences
Reprogramming CRISPR–Cas enzymes for customized genome editing Nature
Top ETFs Tracking CRISPR Gene Editing for 2026 The Motley Fool
Highlight: CRISPR Gene Editing Exposes Hidden Switch in Inflammatory Receptor CRISPR Medicine
CRISPR vs cholesterol: can gene editing prevent heart disease? Nature
The hidden risks of CRISPR/Cas: structural variations and genome integrity Nature
Characterizing and controlling CRISPR repair outcomes in nondividing human cells Nature
First CRISPR horses spark controversy: what’s next for gene-edited animals? Nature
Could CRISPR really cure these diseases? Labiotech.eu
The Gene‑Therapy Breakthrough Story You'll Be Mad You Ignored at These Prices The Motley Fool
A boost for the precision of genome editing MIT News
CRISPR gene-editing works to reduce high cholesterol in a new study NPR
Cleveland Clinic First-In-Human Trial of CRISPR Gene-Editing Therapy Shown to Safely Lower Cholesterol and Triglycerides Cleveland Clinic Newsroom
CRISPR-GPT for agentic automation of gene-editing experiments Nature
Personalized gene editing helped one baby: can it be rolled out widely? Nature
Studies test whether gene-editing can fix high cholesterol. For now, take your medicine Associated Press News
Berkeley Talks: Nobel laureate Jennifer Doudna on CRISPR and the future of gene editing University of California, Berkeley
Could Crispr cure HIV? Chemistry World
LeDNA: a cut-and-build toolkit to democratize CRISPR gene editing technology education Nature
AI expands the repertoire of CRISPR-associated proteins for genome editing Nature